Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Patent Application Number 17881874

17881874
Not Appealed
Patent NumberUS 11944612 B2
Publication NumberUS 20220378770 A1
Filled DateAug 5, 2022
Priority DateDec 4, 2015
Inventor/ApplicantsJoshua Eli Lehrer-Graiwer
Athiwat Hutchaleelaha
Eleanor L. Ramos
Naveen Bejugam
ExaminesCORNET, JEAN P
Art Unit1628
Technology Center1600
Assignments
Global Blood Therapeutics Inc.
Current
Global Blood Therapeutics Inc.Pfizer
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.